Sangamo Therapeutics, Inc. (SGMO)
NASDAQ: SGMO · IEX Real-Time Price · USD
0.320
-0.010 (-3.00%)
At close: Jul 2, 2024, 4:00 PM
0.325
+0.005 (1.53%)
After-hours: Jul 2, 2024, 7:54 PM EDT
Sangamo Therapeutics Revenue
Sangamo Therapeutics had revenue of $18.76M in the twelve months ending March 31, 2024, down -92.22% year-over-year. Revenue in the quarter ending March 31, 2024 was $481.00K, a -99.70% decrease year-over-year. In the year 2023, Sangamo Therapeutics had annual revenue of $176.23M with 58.34% growth.
Revenue (ttm)
$18.76M
Revenue Growth
-92.22%
P/S Ratio
3.54
Revenue / Employee
$46,311
Employees
405
Market Cap
66.42M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 176.23M | 64.93M | 58.34% |
Dec 31, 2022 | 111.30M | 598.00K | 0.54% |
Dec 31, 2021 | 110.70M | -7.49M | -6.34% |
Dec 31, 2020 | 118.19M | 15.76M | 15.39% |
Dec 31, 2019 | 102.43M | 17.98M | 21.29% |
Dec 31, 2018 | 84.45M | 47.89M | 130.95% |
Dec 31, 2017 | 36.57M | 17.18M | 88.60% |
Dec 31, 2016 | 19.39M | -20.15M | -50.96% |
Dec 31, 2015 | 39.54M | -6.33M | -13.80% |
Dec 31, 2014 | 45.87M | 21.74M | 90.07% |
Dec 31, 2013 | 24.13M | 2.48M | 11.44% |
Dec 31, 2012 | 21.66M | 11.34M | 109.86% |
Dec 31, 2011 | 10.32M | -10.49M | -50.40% |
Dec 31, 2010 | 20.81M | -1.38M | -6.23% |
Dec 31, 2009 | 22.19M | 6.00M | 37.08% |
Dec 31, 2008 | 16.19M | 7.09M | 77.91% |
Dec 31, 2007 | 9.10M | 1.21M | 15.38% |
Dec 31, 2006 | 7.89M | 5.40M | 217.43% |
Dec 31, 2005 | 2.48M | 1.17M | 88.90% |
Dec 31, 2004 | 1.32M | -1.26M | -49.01% |
Dec 31, 2003 | 2.58M | -1.76M | -40.62% |
Dec 31, 2002 | 4.34M | -542.00K | -11.10% |
Dec 31, 2001 | 4.89M | 1.45M | 42.30% |
Dec 31, 2000 | 3.43M | 1.25M | 57.33% |
Dec 31, 1999 | 2.18M | 144.00K | 7.07% |
Dec 31, 1998 | 2.04M | 886.00K | 76.91% |
Dec 31, 1997 | 1.15M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Precision BioSciences | 57.53M |
Champions Oncology | 49.22M |
Marinus Pharmaceuticals | 28.29M |
Celularity | 14.79M |
Serina Therapeutics | 3.15M |
Nutriband | 2.02M |
SGMO News
- 7 weeks ago - Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2024 Financial Results - Business Wire
- 7 weeks ago - Sangamo Therapeutics Presents Next-Generation Modular Integrase Technology Engineered to Enable Large-Scale Genome Editing - Business Wire
- 2 months ago - Sangamo Therapeutics Announces First Quarter 2024 Conference Call and Webcast - Business Wire
- 2 months ago - Sangamo Therapeutics to Present Neurology-Focused Pre-Clinical Data From Its Epigenetic Regulation, Capsid Delivery and Genome Engineering Platforms at the 27th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT) - Business Wire
- 3 months ago - Sangamo Therapeutics Announces Pricing of $24.0 Million Registered Direct Offering - Business Wire
- 3 months ago - Sangamo Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results - Business Wire
- 3 months ago - Sangamo Therapeutics Announces Data From Novel Proprietary Neurotropic AAV Capsid Demonstrating Industry-leading Blood-brain Barrier Penetration and Brain Transduction in NHPs - Business Wire
- 4 months ago - Sangamo Therapeutics Announces Fourth Quarter and Full Year 2023 Conference Call and Webcast - Business Wire